Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07206563
What this trial is testing

Penfluridol for Relapsed/Refractory Small Cell Cancers

Who this might be right for
Small Cell CarcinomaSmall Cell Carcinoma of LungSmall Cell Lung Cancer ( SCLC )+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 33
Testing effectiveness (Phase 2)Study completedNCT00064064
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vion Pharmaceuticals
Large-scale testing (Phase 3)WithdrawnNCT00041171
What this trial is testing

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Adult Solid TumorBreast CancerHead and Neck Cancer+3 more
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00245063
What this trial is testing

AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung Cancer
National Cancer Institute (NCI) 25
Early research (Phase 1)Study completedNCT03801902
What this trial is testing

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaLocally Recurrent Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8+2 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Study completedNCT00729612
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Greg Otterson 63
Not applicableStudy completedNCT02616211
What this trial is testing

An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors

Who this might be right for
Adenocarcinoma of LungLung NeoplasmCancer of Lung+4 more
Mayo Clinic 15
Testing effectiveness (Phase 2)Study completedNCT00101283
What this trial is testing

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Eastern Cooperative Oncology Group 32
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT01503177
What this trial is testing

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Recurrent Malignant MesotheliomaStage IA Malignant MesotheliomaStage IB Malignant Mesothelioma+3 more
Mayo Clinic 15
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Early research (Phase 1)Study completedNCT00004930
What this trial is testing

Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases

Who this might be right for
Lung CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Post-approval studies (Phase 4)Study completedNCT04541706
What this trial is testing

Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Pfizer 100
Testing effectiveness (Phase 2)Study completedNCT00489008
What this trial is testing

SRS Study in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 141
Testing effectiveness (Phase 2)Study completedNCT00234052
What this trial is testing

Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Northwestern University 51
Not applicableNot Yet RecruitingNCT07588347
What this trial is testing

Construction and Preliminary Evaluation of Dyadic Acceptance and Commitment Therapy for Couples With Fear of Lung Cancer Recurrence

Who this might be right for
Lung NeoplasmsAcceptance and Commitment TherapySpouses
Feifei Huang 72
Large-scale testing (Phase 3)Study completedNCT02477826
What this trial is testing

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 2,747
Testing effectiveness (Phase 2)Ended earlyNCT00040768
What this trial is testing

Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Ended earlyNCT00470548
What this trial is testing

Abraxane and Alimta in Advanced Solid Tumors

Who this might be right for
Breast CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 49
Next Page